[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
PubMed=1732748 [NCBI, ExPASy, EBI, Israel, Japan]
Yi T.,
Cleveland J.L.,
Ihle J.N.;
"Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13.";
Mol. Cell. Biol. 12:836-846(1992).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
TISSUE=Mammary gland;
DOI=10.1038/352736a0; PubMed=1652101 [NCBI, ExPASy, EBI, Israel, Japan]
Shen S.H.,
Bastien L.,
Posner B.I.,
Chretien P.;
"A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases.";
Nature 352:736-739(1991).
|
[3]
|
ERRATUM, AND SEQUENCE REVISION.
Shen S.H.,
Bastien L.,
Posner B.I.,
Chretien P.;
Nature 353:868-868(1991).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
PubMed=1736296 [NCBI, ExPASy, EBI, Israel, Japan]
Plutzky J.,
Neel B.G.,
Rosenberg R.D.;
"Isolation of a src homology 2-containing tyrosine phosphatase.";
Proc. Natl. Acad. Sci. U.S.A. 89:1123-1127(1992).
|
[5]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3).
DOI=10.1006/geno.1995.1020; PubMed=7665165 [NCBI, ExPASy, EBI, Israel, Japan]
Banville D.,
Stocco R.,
Shen S.H.;
"Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts.";
Genomics 27:165-173(1995).
|
[6]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=9074930 [NCBI, ExPASy, EBI, Israel, Japan]
Ansari-Lari M.A.,
Shen Y.,
Muzny D.M.,
Lee W.,
Gibbs R.A.;
"Large-scale sequencing in human chromosome 12p13: experimental and computational gene structure determination.";
Genome Res. 7:268-280(1997).
|
[7]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
Oka T.,
Ouchida M.;
"Gene silencing of SHP-1 gene in leukemias/lymphomas by aberrant methylation.";
Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
|
[8]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Placenta;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[9]
|
PHOSPHORYLATION.
PubMed=7781604 [NCBI, ExPASy, EBI, Israel, Japan]
Li R.Y.,
Gaits F.,
Ragab A.,
Ragab-Thomas J.M.F.,
Chap H.;
"Tyrosine phosphorylation of an SH2-containing protein tyrosine phosphatase is coupled to platelet thrombin receptor via a pertussis toxin-sensitive heterotrimeric G-protein.";
EMBO J. 14:2519-2526(1995).
|
[10]
|
INTERACTION WITH LILRB1.
DOI=10.1016/S1074-7613(00)80529-4; PubMed=9285411 [NCBI, ExPASy, EBI, Israel, Japan]
Cosman D.,
Fanger N.,
Borges L.,
Kubin M.,
Chin W.,
Peterson L.,
Hsu M.-L.;
"A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.";
Immunity 7:273-282(1997).
|
[11]
|
INTERACTION WITH LILRB2.
DOI=10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; PubMed=9842885 [NCBI, ExPASy, EBI, Israel, Japan]
Fanger N.A.,
Cosman D.,
Peterson L.,
Braddy S.C.,
Maliszewski C.R.,
Borges L.;
"The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes.";
Eur. J. Immunol. 28:3423-3434(1998).
|
[12]
|
INTERACTION WITH PTPNS1.
DOI=10.1074/jbc.273.35.22719; PubMed=9712903 [NCBI, ExPASy, EBI, Israel, Japan]
Veillette A.,
Thibaudeau E.,
Latour S.;
"High expression of inhibitory receptor SHPS-1 and its association with protein tyrosine phosphatase SHP-1 in macrophages.";
J. Biol. Chem. 273:22719-22728(1998).
|
[13]
|
INTERACTION WITH FCRL2 AND FCRL3.
DOI=10.1006/bbrc.2000.4213; PubMed=11162587 [NCBI, ExPASy, EBI, Israel, Japan]
Xu M.-J.,
Zhao R.,
Zhao Z.J.;
"Molecular cloning and characterization of SPAP1, an inhibitory receptor.";
Biochem. Biophys. Res. Commun. 280:768-775(2001).
|
[14]
|
INTERACTION WITH CD84.
DOI=10.1006/clim.2001.5035; PubMed=11414741 [NCBI, ExPASy, EBI, Israel, Japan]
Lewis J.,
Eiben L.J.,
Nelson D.L.,
Cohen J.I.,
Nichols K.E.,
Ochs H.D.,
Notarangelo L.D.,
Duckett C.S.;
"Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.";
Clin. Immunol. 100:15-23(2001).
|
[15]
|
INTERACTION WITH FCRL4.
DOI=10.1073/pnas.1935944100; PubMed=14597715 [NCBI, ExPASy, EBI, Israel, Japan]
Ehrhardt G.R.A.,
Davis R.S.,
Hsu J.T.,
Leu C.-M.,
Ehrhardt A.,
Cooper M.D.;
"The inhibitory potential of Fc receptor homolog 4 on memory B cells.";
Proc. Natl. Acad. Sci. U.S.A. 100:13489-13494(2003).
|
[16]
|
INTERACTION WITH CD300LF.
DOI=10.1016/j.bbrc.2004.05.065; PubMed=15184070 [NCBI, ExPASy, EBI, Israel, Japan]
Sui L.,
Li N.,
Liu Q.,
Zhang W.,
Wan T.,
Wang B.,
Luo K.,
Sun H.,
Cao X.;
"IgSF13, a novel human inhibitory receptor of the immunoglobulin superfamily, is preferentially expressed in dendritic cells and monocytes.";
Biochem. Biophys. Res. Commun. 319:920-928(2004).
|
[17]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-536 AND TYR-564, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K.,
Guo A.,
Zeng Q.,
Possemato A.,
Yu J.,
Haack H.,
Nardone J.,
Lee K.,
Reeves C.,
Li Y.,
Hu Y.,
Tan Z.,
Stokes M.,
Sullivan L.,
Mitchell J.,
Wetzel R.,
Macneill J.,
Ren J.M.,
Yuan J., ![]()
Bakalarski C.E.,
Villen J.,
Kornhauser J.M.,
Smith B.,
Li D.,
Zhou X.,
Gygi S.P.,
Gu T.-L.,
Polakiewicz R.D.,
Rush J.,
Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
|
[18]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-509, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K.,
Sugiyama N.,
Kyono Y.,
Tomita M.,
Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
|
[19]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 248-399.
DOI=10.1074/jbc.273.43.28199; PubMed=9774441 [NCBI, ExPASy, EBI, Israel, Japan]
Yang J.,
Liang X.,
Niu T.,
Meng W.,
Zhao Z.,
Zhou G.W.;
"Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1.";
J. Biol. Chem. 273:28199-28207(1998).
|
[20]
|
STRUCTURE BY NMR OF 110-214.
RIKEN structural genomics initiative (RSGI);
"Solution structures of the SH2 domain of human protein-tyrosine phosphatase SHP-1.";
Submitted (NOV-2005) to the PDB data bank.
|
|
ExPASy Home page
APAF Australia
